Stock Research: ICON

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

ICON

NasdaqGS:ICLR IE0005711209
6
  • Value
    37
  • Growth
    5
  • Safety
    Safety
    57
  • Combined
    6
  • Sentiment
    12
  • 360° View
    360° View
    6
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

ICON Public Limited Company is a healthcare intelligence and clinical research organization providing outsourced services to pharmaceutical, biotechnology, and medical device companies. It operates across sectors like biosimilars, medical devices, and pharmaceuticals. In the last fiscal year, the company had a market cap of $11657 million, profits of $2444 million, revenue of $8282 million, and 41900 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 6 (better than 6% compared with alternatives), overall professional sentiment and financial characteristics for the stock ICON are critical, mostly below average. The 360° View is based on consolidating four consolidated indicators, with three out of four indicators below average for ICON. Only the consolidated Value Rank has an attractive rank of 57, which means that the share price of ICON is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means that the stock price is lower than for 57% of alternative stocks in the same industry. All other consolidated ranks are below average. The consolidated Growth Rank has a low rank of 5, which means that the company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. The consolidated Safety Rank has a riskier rank of 37, meaning the company has a riskier financing structure than 63% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, professionals are more pessimistic about the stock than for 88% of alternative investment opportunities, reflected in the consolidated Sentiment Rank of 12. ...read more

more
Index
Employee Health EU
NASDAQ
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 30-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
57 30 19 33
Growth
5 30 95 97
Safety
Safety
37 34 14 82
Sentiment
12 45 63 38
360° View
360° View
6 9 50 77
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
41 74 68 49
Opinions Change
11 52 75 42
Pro Holdings
n/a n/a n/a n/a
Market Pulse
21 25 30 38
Sentiment
12 45 63 38
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
57 30 19 33
Growth
5 30 95 97
Safety Safety
37 34 14 82
Combined
6 6 34 90
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
56 38 28 25
Price vs. Earnings (P/E)
66 53 38 39
Price vs. Book (P/B)
73 58 34 65
Dividend Yield
1 1 1 1
Value
57 30 19 33
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
6 18 62 88
Profit Growth
17 60 70 70
Capital Growth
37 73 73 93
Stock Returns
7 12 91 81
Growth
5 30 95 97
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
54 59 46 74
Refinancing
25 40 25 35
Liquidity
27 26 16 73
Safety Safety
37 34 14 82

Similar Stocks

Discover high‑ranked alternatives to ICON and broaden your portfolio horizons.

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.

BUSE:RICHTER
Country: Hungary
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

Ipsen

ENXTPA:IPN
Country: France
Industry: Pharmaceuticals
Size: Large
Full Stock Analysis

thyssenkrupp

XTRA:TKA
Country: Germany
Industry: Steel
Size: X-Large
Full Stock Analysis

SSE

LSE:SSE
Country: United Kingdom
Industry: Electric Utilities
Size: X-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.